Cancer Clinical Trial -Takeda - TAK-981-1502

A Study of TAK-981 Given With Pembrolizumab in Participants With Select Advanced or Metastatic Solid Tumors

Device

Immunotherapy

Drug

TAK-981, Pembrolizumab

Phase

Phase II

Condition

Cervical Colorectal Lung, Melanoma

Keywords

Immunotherapy